The topics covered in this whitepaper include:
WHITEPAPER
AUTHOR:
![Company team](/web/image/4317/linda-pullan-headshot-158%C3%97159.jpg)
Linda Pullan, PhD
Pullan Consulting
![Company team](/web/image/4388/james-mccarthy-headshot-120%C3%97120%281%29.png)
James A. McCarthy, CLP, MBA
Corporate and Business Development, Alliance Management, CorpDev Ventures
![Company team](/web/image/4389/natalie-mirutenko-headshot-120%C3%97120%281%29.png)
Natalie Mirutenko, PhD
Transaction and Due Diligence Senior Director for the Center of External Innovation at Takeda
![Company team](/web/image/4390/david-snitman-headshot-120%C3%97120%281%29.jpg)
David L. Snitman, PhD
Partner, DL Snitman Inc and Former COO, Array BioPharma
![Company team](/web/image/4385/patrick-gattari-headshot-120%C3%97120.jpg)
Patrick Gattari, JD
Partner, McDonnell Boehnen Hulbert & Berghoff
![Company team](/web/image/4386/anne-marie-costelloe-headshot-120%C3%97120.jpg)
Ann-Marie Costelloe, AFBPS
Psychologist | Executive Consultant, Somerville Partners
![Company team](/web/image/4387/william-gangi-headshot-250x250.jpg)
William Gangi, MS, MBA
Director, Due Diligence Program Manager - Corporate Development, Shire
![sharevault free trial or biopharma](/web/image/4391/bio-25-logo-1200x294.png)
![sharevault demo or biopharma](/web/image/4304/LES-logo.jpg)